Karen Ann Shulman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3205 Glacier Ridge Rd, Middleton, WI 53562 Phone: 608-268-6211 Fax: 608-620-0242 |
Tia Marie Vaccaro-mussehl, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3030 Laura Ln Ste 130, Middleton, WI 53562 Phone: 888-688-4746 |
Daniel R Jarzemsky, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1206 Devonshire Ct, Middleton, WI 53562 Phone: 608-220-8831 |
Dr. Richard Edgar Rieselbach, M.D. Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 2711 Allen Blvd, Middleton, WI 53562 Phone: 608-827-2308 Fax: 608-827-2344 |
Mark Isaacson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6947 Harmony Way, Middleton, WI 53562 Phone: 608-831-0106 |
Arthur Waldman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1003 Rooster Run, Middleton, WI 53562 Phone: 608-203-5085 |
Kim Yung Sook Thompson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2275 Deming Way, Suite 240, Middleton, WI 53562 Phone: 608-662-7762 Fax: 608-662-7769 |
Pamela A Olson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5413 Larkspur Rd, Middleton, WI 53562 Phone: 608-831-8860 |
Joseph P Spurgeon, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2275 Deming Way, Suite 220, Middleton, WI 53562 Phone: 608-417-8388 |
News Archive
In a letter submitted today to the U.S. Food and Drug Administration (FDA), the National Organization for Rare Disorders (NORD) urged Commissioner Margaret Hamburg to give serious consideration to the concerns of the rare disease community when setting policy regarding official names for biologics, including biosimilars.
The latest research into the health effects and safety of a soy-based compound called S-equol was described in talks and presentations by experts at a special session on Tuesday, Oct. 19 during the Ninth International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment, held Oct. 16 to 19 in Washington, D.C.
A small pilot study suggests that testosterone treatment is safe, well tolerated and may reduce symptoms, slow brain degeneration and increase muscle mass in men with relapsing-remitting multiple sclerosis, the most common form of the disease, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.
Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., (SZSE: 300147), have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.
› Verified 2 days ago